Dementia ‘linked’ to common over-the-counter drugs — Hayfever drugs raise risk of Alzheimer’s disease, say scientists – Over-the counter hayfever tables, sleeping pills or asthma drugs significantly raise the risk of developing dementia, a study has shown.
Depression, behavior changes may start in Alzheimer’s even before memory changes – Depression and other behavior changes may show up in people who will later develop Alzheimer’s disease even before they start having memory problems, reported by researchers in the medical journal of the American Academy of Neurology.
Anxiety can damage brain — Accelerate conversion to Alzheimer’s for those with mild cognitive impairment – People with mild cognitive impairment (MCI) are at increased risk of converting to Alzheimer’s disease within a few years, but a new study warns the risk increases significantly if they suffer from anxiety.
High good and low bad cholesterol levels are healthy for the brain, too – High levels of “good” cholesterol and low levels of “bad” cholesterol are correlated with lower levels of the amyloid plaque deposition in the brain that is a hallmark of Alzheimer’s disease, UC Davis researchers have found.
Vitamin E May Delay Decline in Mild-to-Moderate Alzheimer’s Disease — Study Shows Benefit in Activities of Daily Living and Savings in Caregiver Time with Vitamin E – A new research suggests that alpha tocepherol, fat-soluble Vitamin E and antioxidant, may slow functional decline (problems with daily activities such as shopping, preparing meals, planning, and traveling) in patients with mild-to-moderate Alzheimer’s disease and decrease caregiver burden.
Regular physical activity in later life boosts likelihood of ‘healthy aging’ up to sevenfold — Helps stave off major ill health and dementia even for those getting started relatively late – It’s never too late to get physically active, with even those starting relatively late in life reaping significant health benefits, reveals researchers. Four years of sustained regular physical activity boosted the likelihood of healthy ageing sevenfold compared with consistent inactivity.
Comprehensive Parkinson’s Biomarker Test Has Prognostic and Diagnostic Value, Penn Medicine Team Reports — First Biomarker Results from Parkinson’s Progression Markers Initiative Detect Differences in Subtypes of Parkinson’s Disease – The first biomarker results reported from the Parkinson’s Progression Markers Initiative (PPMI), showing that a comprehensive test of protein biomarkers in spinal fluid have prognostic and diagnostic value in early stages of Parkinson’s disease.